Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NONPROFIT ORGANIZATIONS' UNRELATED BUSINESS INCOME TAX

Executive Summary

NONPROFIT ORGANIZATIONS' UNRELATED BUSINESS INCOME TAX was discussed at a closed-door meeting of the House Ways and Means/Oversight Subcommittee August 2. Subcommittee Chairman Pickle (D-Tex.) called the meeting in an effort to move the subcommittee's 1988 recommendations on UBIT issues to the full committee for review. Ways and Means Chairman Rostenkowski (D-Ill.) has indicated that he wants the full committee to assess the recommendations, according to subcommittee staff. The subcommittee reportedly made no progress in terms of selecting specific legislative recommendations. Pickle asked members to familiarize themselves with UBIT issues during the summer recess. He is planning to hold another subcommittee session on UBIT in September. Last year, the panel developed a list of possible changes in the UBIT law to tax certain activities of nonprofit entities. One option floated by the subcommittee would require nonprofits to pay tax on sales and rentals of pharmaceuticals and medical equipment.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS016051

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel